Basit öğe kaydını göster

dc.contributor.authorAgirbasli, Mehmet
dc.contributor.authorCan, Guenay
dc.contributor.authorHergenc, Guelay
dc.contributor.authorKAYA, Zekeriya
dc.contributor.authorUenaltuna, Nihan
dc.contributor.authorONAT, Altan
dc.date.accessioned2021-03-02T20:21:46Z
dc.date.available2021-03-02T20:21:46Z
dc.date.issued2009
dc.identifier.citationONAT A., Hergenc G., Agirbasli M., KAYA Z., Can G., Uenaltuna N., "Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking", CLINICAL CHEMISTRY AND LABORATORY MEDICINE, cilt.47, sa.2, ss.208-215, 2009
dc.identifier.issn1434-6621
dc.identifier.otherav_019bedb6-5dcb-4959-a89b-0ef23c060a32
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/7050
dc.identifier.urihttps://doi.org/10.1515/cclm.2009.018
dc.description.abstractBackground: Correlates of preheparin serum lipoprotein lipase (LPL) mass and its associations with the likelihood of metabolic syndrome (MS) and coronary heart disease (CHD) were investigated.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.subjectKlinik Tıp
dc.subjectTıp
dc.titlePreheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking
dc.typeMakale
dc.relation.journalCLINICAL CHEMISTRY AND LABORATORY MEDICINE
dc.contributor.departmentTurkish Heart Foundation , ,
dc.identifier.volume47
dc.identifier.issue2
dc.identifier.startpage208
dc.identifier.endpage215
dc.contributor.firstauthorID90643


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster